Susan E Spiller

Summary

Affiliation: University of Alabama at Birmingham
Country: USA

Publications

  1. pmc Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo
    Susan E Spiller
    Department of Pediatrics, University of Alabama at Birmingham, 35294, USA
    BMC Cancer 11:136. 2011
  2. ncbi request reprint Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)
    Susan E Spiller
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    J Neurooncol 87:133-41. 2008
  3. doi request reprint Biophysical properties of human medulloblastoma cells
    Nola Jean Ernest
    Department of Pediatrics, University of Alabama School of Medicine, 1719 6th Ave S, CIRC 252A, Birmingham, AL 35294, USA
    J Membr Biol 237:59-69. 2010

Collaborators

Detail Information

Publications3

  1. pmc Inhibition of nuclear factor kappa-B signaling reduces growth in medulloblastoma in vivo
    Susan E Spiller
    Department of Pediatrics, University of Alabama at Birmingham, 35294, USA
    BMC Cancer 11:136. 2011
    ..Nuclear factor kappa-B (NFκB) is a signaling pathway that controls transcriptional activation of genes important for tight regulation of many cellular processes and is aberrantly expressed in many types of cancer...
  2. ncbi request reprint Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA)
    Susan E Spiller
    Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    J Neurooncol 87:133-41. 2008
    ..We tested the hypothesis that these drugs additively induce BMP-2 transcription and apoptosis...
  3. doi request reprint Biophysical properties of human medulloblastoma cells
    Nola Jean Ernest
    Department of Pediatrics, University of Alabama School of Medicine, 1719 6th Ave S, CIRC 252A, Birmingham, AL 35294, USA
    J Membr Biol 237:59-69. 2010
    ..This supports the notion that the malignant phenotype of medulloblastoma is characterized by unique changes in ion channel expression...